Lewis-Smith, David http://orcid.org/0000-0002-1735-8178
Ganesan, Shiva http://orcid.org/0000-0002-2518-6505
Galer, Peter D. http://orcid.org/0000-0002-6408-0906
Helbig, Katherine L.
McKeown, Sarah E.
O’Brien, Margaret
Khankhanian, Pouya
Kaufman, Michael C. http://orcid.org/0000-0003-2718-296X
Gonzalez, Alexander K.
Felmeister, Alex S. http://orcid.org/0000-0001-5735-6305
Krause, Roland http://orcid.org/0000-0001-9938-7126
Ellis, Colin A.
Helbig, Ingo http://orcid.org/0000-0001-8486-0558
Funding for this research was provided by:
Hartwell Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (U54 NS108874)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR001878)
Institute for Translational Medicine and Therapeutics
Wellcome Trust (203914/Z/16/Z)
Article History
Received: 27 November 2020
Revised: 30 April 2021
Accepted: 4 May 2021
First Online: 24 May 2021
Compliance with ethical standards
:
: IH serves on the Scientific Advisory Board of Biogen. The other authors declare no conflict of interest.